(Q63340917)
Statements
An Open-label, Multicenter, Dose-Escalation Safety and Pharmacokinetic Study of a Recombinant Coagulation Factor IX Albumin Fusion Protein (rIX-FP) in Subjects With Hemophilia B (English)
0 references
October 2010
0 references
July 2011
0 references
25
0 references
12 year
0 references
65 year
0 references